Investigation of the Therapeutic, Physicochemical, and Pharmaceutical Properties of Bioactive Compounds from Citrullus colocynthis

Document Type : Original Article

Author

1 Behbahan Faculty of Medical Sciences, Behbahan, Iran.

2 Department of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.

10.30476/tips.2025.105771.1282

Abstract

Citrullus colocynthis is a perennial plant found in arid regions with medicinal properties. Its fruits contain bioactive compounds that offer laxative, anti-diabetic, and anti-cancer effects. However, there are toxicity risks associated with its use, potentially leading to gastrointestinal issues and kidney damage if not used properly, necessitating professional guidance. A literature review was conducted on Citrullus colocynthis, also known as bitter cucumber, to explore its traditional medicinal uses. The team searched databases for information on its herbal therapy potential and predicted properties using the SwissADME platform, focusing on solubility and permeability. Cucurbitacins, with larger molecular weights ranging from 516 to 718 daltons, have poor solubility and absorption compared to smaller alkaloids like Kaempferol and Quercetin. These alkaloids can cross the blood-brain barrier more effectively due to their higher Fraction Csp3 indices. Solubility is influenced by factors such as rotatable bond counts, hydrogen bond interactions, polar surface area, and lipophilicity, as indicated by Ilogp and Consensus Log P. Structural characteristics play a significant role in the solubility of flavonoids and phenolic acids. To improve bioavailability, it is recommended to use intravenous solutions and simpler structures. Smaller drug molecules can enhance bioavailability and cross biological barriers, such as the blood-brain barrier. Alkaloids adhere to Lipinski’s rule and exhibit better permeability. Molecular properties play a crucial role in drug efficacy. Citrullus colocynthis demonstrates anti-diabetic effects by improving glucose regulation, with previous trials confirming its safety and efficacy for further research.

Highlights

Roohallah Yousefi (Google Scholar)

 

Keywords

References

1.    Li QY, Munawar M, Saeed M, Shen JQ, Khan MS, Noreen S, et al. Citrullus colocynthis (L.) Schrad (Bitter Apple Fruit): Promising Traditional Uses, Pharmacological Effects, Aspects, and Potential Applications. Front Pharmacol. 2022 Jan 25;12:791049. doi: 10.3389/fphar.2021.791049. PMID: 35145403; PMCID: PMC8821906.
2.    Rao V, Poonia A. Citrullus colocynthis (bitter apple): Bioactive compounds, nutritional profile, nutraceutical properties and potential food applications: A review. Food Production, Processing and Nutrition. 2023 Feb 1;5(1):4. doi: 10.1186/s43014-022-00118-9.
3.    Hussain AI, Rathore HA, Sattar MZ, Chatha SA, Sarker SD, Gilani AH. Citrullus colocynthis (L.) Schrad (bitter apple fruit): a review of its phytochemistry, pharmacology, traditional uses and nutritional potential. J Ethnopharmacol. 2014 Aug 8;155(1):54-66. doi: 10.1016/j.jep.2014.06.011. Epub 2014 Jun 14. PMID: 24936768.
4.    Adam SE, Al-Yahya MA, Al-Farhan AH. Response of Najdi sheep to oral administration of Citrullus colocynthis fruits, Nerium oleander leaves or their mixture. Small Rumin Res. 2001 Jun;40(3):239-244. doi: 10.1016/s0921-4488(01)00184-5. PMID: 11323208.
5.    Zheng MS, Liu YS, Yuan T, Liu LY, Li ZY, Huang XL. [Research progress on chemical constituents of Citrullus colocynthis and their pharmacological effects]. Zhongguo Zhong Yao Za Zhi. 2020 Feb;45(4):816-824. Chinese. doi: 10.19540/j.cnki.cjcmm.20191104.201. PMID: 32237481.
6.    Nayab D, Ali D, Arshad N, Malik A, Choudhary MI, Ahmed Z. Cucurbitacin glucosides from Citrullus colocynthis. Nat Prod Res. 2006 May 10;20(5):409-13. doi: 10.1080/14786410500044997. PMID: 16644537.
7.    Cheng X, Qin M, Chen R, Jia Y, Zhu Q, Chen G, et al. Citrullus colocynthis (L.) Schrad.: A Promising Pharmaceutical Resource for Multiple Diseases. Molecules. 2023 Aug 24;28(17):6221. doi: 10.3390/molecules28176221. PMID: 37687049; PMCID: PMC10488440.
8.    Shi C, Karim S, Wang C, Zhao M, Murtaza G. A review on antidiabetic activity of Citrullus colocynthis Schrad. Acta Pol Pharm. 2014 May-Jun;71(3):363-7. PMID: 25265814.
9.    Jeon JH, Lee HS. Biofunctional constituent isolated from Citrullus colocynthis fruits and structure-activity relationships of its analogues show acaricidal and insecticidal efficacy. J Agric Food Chem. 2014 Aug 27;62(34):8663-7. doi: 10.1021/jf502536e. Epub 2014 Aug 18. PMID: 25110971.
10.    Cheraghi Niroumand M, Farzaei MH, Karimpour Razkenari E, Amin G, Khanavi M, Akbarzadeh T, et al. An Evidence-Based Review on Medicinal Plants Used as Insecticide and Insect Repellent in Traditional Iranian Medicine. Iran Red Crescent Med J. 2016 Feb 13;18(2):e22361. doi: 10.5812/ircmj.22361. PMID: 27186389; PMCID: PMC4867175.
11.    Gurudeeban S, Satyavani K, Ramanathan T. Bitter apple (Citrullus colocynthis): An overview of chemical composition and biomedical potentials. Asian J Plant Sci. 2010;9(7):394. doi: 10.3923/ajps.2010.394.401
12.    Gowri SS, Priyavardhini S, Vasantha K, Umadevi M. Antibacterial activity on Citrullus colocynthis Leaf extract. Anc Sci Life. 2009 Jul;29(1):12-3. PMID: 22557336; PMCID: PMC3336298.
13.    Yoshikawa M, Morikawa T, Kobayashi H, Nakamura A, Matsuhira K, Nakamura S, et al. Bioactive saponins and glycosides. XXVII. Structures of new cucurbitane-type triterpene glycosides and antiallergic constituents from Citrullus colocynthis. Chem Pharm Bull (Tokyo). 2007 Mar;55(3):428-34. doi: 10.1248/cpb.55.428. PMID: 17329885.
14.    Seger C, Sturm S, Mair ME, Ellmerer EP, Stuppner H. 1H and 13C NMR signal assignment of cucurbitacin derivatives from Citrullus colocynthis (L.) Schrader and Ecballium elaterium L. (Cucurbitaceae). Magn Reson Chem. 2005 Jun;43(6):489-91. doi: 10.1002/mrc.1570. PMID: 15772995.
15.    Chawech R, Jarraya R, Girardi C, Vansteelandt M, Marti G, Nasri I, et al. Cucurbitacins from the Leaves of Citrullus colocynthis (L.) Schrad. Molecules. 2015 Sep 30;20(10):18001-15. doi: 10.3390/molecules201018001. PMID: 26437392; PMCID: PMC6332406.
16.    Al-Snafi AE. Chemical constituents and pharmacological effects of Citrullus colocynthis-A review. IOSR J Pharm. 2016 Mar;6(3):57-67.
17.    Ahmed M, Sajid AR, Javeed A, Aslam M, Ahsan T, Hussain D, Mateen A, Li X, Qin P, Ji M. Antioxidant, antifungal, and aphicidal activity of the triterpenoids spinasterol and 22,23-dihydrospinasterol from leaves of Citrullus colocynthis L. Sci Rep. 2022 Mar 22;12(1):4910. doi: 10.1038/s41598-022-08999-z. PMID: 35318417; PMCID: PMC8940894.
18.    Elansary HO, Szopa A, Kubica P, Ekiert H, Ali HM, Elshikh MS, et al. Bioactivities of Traditional Medicinal Plants in Alexandria. Evid Based Complement Alternat Med. 2018 Jan 31;2018:1463579. doi: 10.1155/2018/1463579. PMID: 29636772; PMCID: PMC5831234.
19.    Nehdi IA, Sbihi H, Tan CP, Al-Resayes SI. Evaluation and characterisation of Citrullus colocynthis (L.) Schrad seed oil: Comparison with Helianthus annuus (sunflower) seed oil. Food chemistry. 2013 Jan 15;136(2):348-53. doi: 10.1016/j.foodchem.2012.09.009.
20.    Bhasin A, Singh S, Garg R. Nutritional and medical importance of Citrullus colocynthis-A review. Plant Arch. 2020;20(2):3400-6.  
21.    Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A, Han L, He J, He S, Shoemaker BA, Wang J, Yu B, Zhang J, Bryant SH. PubChem Substance and Compound databases. Nucleic Acids Res. 2016 Jan 4;44(D1):D1202-13. doi: 10.1093/nar/gkv951. Epub 2015 Sep 22. PMID: 26400175; PMCID: PMC4702940.
22.    Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017 Mar 3;7:42717. doi: 10.1038/srep42717. PMID: 28256516; PMCID: PMC5335600.
23.    Daina A, Michielin O, Zoete V. iLOGP: a simple, robust, and efficient description of n-octanol/water partition coefficient for drug design using the GB/SA approach. J Chem Inf Model. 2014 Dec 22;54(12):3284-301. doi: 10.1021/ci500467k. Epub 2014 Nov 25. PMID: 25382374.
24.    Daina A, Zoete V. A BOILED-Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules. ChemMedChem. 2016 Jun 6;11(11):1117-21. doi: 10.1002/cmdc.201600182. Epub 2016 May 24. PMID: 27218427; PMCID: PMC5089604.
25.    Yousefi R, Mokarmian R, Jamshidi A. Molecular Docking of Pepstatin (A) and Compounds with Structural Similarity to the Molecular Model of Human BACE-1 Enzyme. J Adv Pharm Res. 2023 Oct 1;7(4):181-98. doi: 10.21608/aprh.2023.219909.1223.
26.    Yousefi, R. Investigation of the physicochemical properties and pharmacokinetics of the active compounds in Quercus infectoria gall extract. Trends in Pharmaceutical Sciences, 2024; 10(4): 273-284. doi: 10.30476/tips.2024.102275.1233.
27.    Yousefi R. The molecular docking of specific reverse transcriptase inhibitory ligands onto the molecular model of HIV-1 reverse transcriptase. Trends in Pharmaceutical Sciences. 2024 Jun 1;10(2). doi: 10.30476/tips.2024.102488.1239.
28.    Yousefi R, Mohammadtaghvaei N, Zakerkish M, Yaghooti H, Akhormeh AK, Tavakoli R. Association between plasma levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) and lipids with rs7903146 polymorphisms of the TCF7L2 gene in diabetic patients. Int J Diabetes Dev Ctries. 2019 Apr 1;39:380-6. doi: 10.1007/s13410-018-0647-9.
29.    Cheng X, Qin M, Chen R, Jia Y, Zhu Q, Chen G, Wang A, Ling B, Rong W. Citrullus colocynthis (L.) Schrad.: A Promising Pharmaceutical Resource for Multiple Diseases. Molecules. 2023 Aug 24;28(17):6221. doi: 10.3390/molecules28176221. PMID: 37687049; PMCID: PMC10488440.
30.    Monicaa A, Arthanari A, Sankar S. ANTI DIABETIC POTENTIAL OF CITRULLUS COLOCYNTHIS BY INVITRO AND IN SILICO APPROACH. Obstetrics and Gynaecology Forum. 2024 May 13 (Vol. 34, No. 2s, pp. 438-444). https://www.obstetricsandgynaecologyforum.com/index.php/ogf/article/view/169.
31.    Ebrahimi E, Mohammadzadeh G, Mansouri E, Aberomand M. Effects of hydro-alcoholic leaf extract of Citrullus colocynthis on biochemical factors and histopathological changes in streptozotocin-induced diabetic rats. Jundishapur J Nat Pharm Prod. 2016 Aug 1;11(3):e33214. doi: 10.1016/S2222-1808(16)61101-5.
32.    Drissi F, Lahfa F, Gonzalez T, Peiretti F, Tanti JF, Haddad M, et al. A Citrullus colocynthis fruit extract acutely enhances insulin-induced GLUT4 translocation and glucose uptake in adipocytes by increasing PKB phosphorylation. J Ethnopharmacol. 2021 Apr 24;270:113772. doi: 10.1016/j.jep.2020.113772. Epub 2021 Jan 6. PMID: 33418030.
33.    Barghamdi B, Ghorat F, Asadollahi K, Sayehmiri K, Peyghambari R, Abangah G. Therapeutic effects of Citrullus colocynthis fruit in patients with type II diabetes: A clinical trial study. J Pharm Bioallied Sci. 2016 Apr-Jun;8(2):130-4. doi: 10.4103/0975-7406.171702. PMID: 27134465; PMCID: PMC4832903.
34.    Marzouk B, Marzouk Z, Haloui E, Fenina N, Bouraoui A, Aouni M. Screening of analgesic and anti-inflammatory activities of Citrullus colocynthis from southern Tunisia. J Ethnopharmacol. 2010 Mar 2;128(1):15-9. doi: 10.1016/j.jep.2009.11.027. Epub 2009 Dec 3. PMID: 19962436.
Trends in Pharmaceutical Sciences and Technologies
Volume 11, Issue 3
September 2025
Pages 271-286

Files

Share

How to cite

Statistics